This inventor holds 1 USPTO granted patent. Top assignees: Promiliad Biopharma Inc., University of Connecticut. Active years: 2016.
Company Filing History:
1 out of 1 
1 out of 780 
Years Active: 2016
Title: Grant Sormunen: Innovator in Dihydrofolate Reductase Inhibition
Introduction
Grant Sormunen is a notable inventor based in Athens, OH (US). He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for dihydrofolate reductase. His work is crucial for advancing treatments for various infections.
Latest Patents
Sormunen holds a patent for "Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase." This patent describes compounds that are effective in inhibiting dihydrofolate reductase, which is essential for treating fungal, bacterial, and protozoal infections. The compounds are defined by specific formulas and structures, making them suitable for therapeutic applications.
Career Highlights
Throughout his career, Grant Sormunen has worked with prominent organizations such as Promiliad Biopharma Inc. and the University of Connecticut. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to innovative research.
Collaborations
Some of his notable coworkers include Dennis L. Wright and Amy C. Anderson. Their collaborative efforts have furthered the research and development of effective treatments in the pharmaceutical industry.
Conclusion
Grant Sormunen's work in the field of dihydrofolate reductase inhibition showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his impact on the treatment of infections.